We explore the crucial aspects outlined by the FTC regarding comparative claims in drug and device advertising. 
the paramount importance of transparency in promotional efforts,
the pitfalls associated with broad generalizations, and 
the need for readiness in the face of scrutiny from both the FDA and the FTC.

Providing a valuable intersection of pharmacy, law, and marketing, our short offers a comprehensive guide for navigating the complex landscape of comparative claims in the healthcare industry. 

Support the show

www.kulkarnilawfirm.com